Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 23,220 | 22,927 | 19,226 | 24,658 | 23,408 |
| Receivables | 202,050 | 212,749 | 202,717 | 180,398 | 170,707 |
| Inventories | 54,831 | 50,767 | 49,265 | 53,807 | 58,181 |
| Other current assets | 13,045 | 11,098 | 10,740 | 0 | 0 |
| TOTAL | $308,684 | $312,867 | $296,907 | $301,130 | $291,437 |
| Non-Current Assets | |||||
| PPE Net | 130,829 | 127,731 | 125,418 | 125,697 | 118,665 |
| Intangibles | 173,677 | 172,603 | 172,058 | 171,795 | 171,672 |
| Other Non-Current Assets | 41,926 | 42,242 | 42,133 | 39,910 | 40,899 |
| TOTAL | $346,432 | $342,576 | $339,609 | $337,402 | $331,236 |
| Total Assets | $655,116 | $655,443 | $636,516 | $638,532 | $622,673 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 45 | 623 |
| Accounts payable and accrued liabilities | 55,928 | 54,078 | 55,168 | 45,778 | 51,280 |
| Accrued Expenses | 30,124 | 29,439 | 34,919 | 30,180 | 26,188 |
| TOTAL | $140,956 | $150,750 | $140,510 | $118,882 | $126,177 |
| Non-Current Liabilities | |||||
| Long Term Debt | 250,013 | 241,022 | 234,033 | 213,044 | 206,053 |
| Deferred Revenues | 16,358 | 20,735 | 13,868 | 12,833 | 18,334 |
| Other Non-Current Liabilities | 71,162 | 69,184 | 66,902 | 64,294 | 60,457 |
| TOTAL | $326,682 | $316,786 | $308,093 | $282,818 | $272,343 |
| Total Liabilities | $467,638 | $467,536 | $448,603 | $401,700 | $398,520 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 45,639 | 45,910 | 46,226 | 46,658 | 47,307 |
| Common Shares | 1,233 | 1,233 | 1,233 | 1,233 | 1,376 |
| Retained earnings | 447,612 | 402,951 | 361,255 | 326,058 | 363,903 |
| Other shareholders' equity | -2,477 | -2,627 | -2,575 | 1,779 | 1,966 |
| TOTAL | $187,478 | $187,907 | $187,913 | $236,832 | $224,153 |
| Total Liabilities And Equity | $655,116 | $655,443 | $636,516 | $638,532 | $622,673 |